Loading...
NPI 1518626357 · Chicago, IL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
S K Diagnostics Inc is a clinical medical laboratory provider located in Chicago, Illinois. This profile covers 1 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | S K Diagnostics Inc |
| Address | 6013 N Cicero Ave |
| City | Chicago |
| State | IL |
| ZIP | 60646 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | December 9, 2021 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $21.4M |
| Medicaid | $20.3K |
Billing mix and service line: The provider’s claimed activity is effectively a clinical laboratory operation built around distribution/provision of nonprescription self‑administered COVID‑19 tests, as shown by the dominance of code K1034 (provision of covid-19 test, nonprescription self-administered and self-collected use). The sheer scale of K1034 billing (millions of Medicare claims and thousands of Medicaid claims) indicates the business operates as a high-volume test fulfillment/distribution channel rather than a diversified diagnostic lab offering many different clinical assay codes.
Revenue concentration across payers: The provider’s revenue is highly concentrated — the precomputed top-3 Medicare codes account for 100.0% of Medicare revenue and the top-3 Medicaid codes account for 100.0% of Medicaid revenue. In practical terms K1034 is reported as the single dominant revenue source for both payers, meaning the provider’s financial profile is narrowly tied to one service line.
Payer mix and scale: Reported total Medicare revenue is $21.4M versus total Medicaid revenue of $20.3K, making Medicare the overwhelmingly dominant payer for this provider. This difference in scale indicates the provider is effectively operating as a Medicare-focused entity in terms of revenue exposure and business risk.
Medicare competitive standing and volume: For Medicare, K1034 shows 1.8M claims, $12 avg paid/claim, and $21.8M revenue and is listed as ranking #16 of 30143 providers nationally (100th percentile; extreme outlier). That rank and the millions of claims position the provider as a national-scale participant for this specific code and far above typical national volumes for K1034 billing.
Medicaid competitive standing and local presence: For Medicaid, K1034 shows 6.1K claims, $3 avg paid/claim, and $18.2K revenue and is listed as ranking #4 of 59 providers in-state (95th percentile; notably above typical state volume). While the provider is a top in-state reporter for this code, the absolute Medicaid revenue remains small relative to its Medicare business.
Tenure and implied operational ramp: The NPI was enumerated 2021-12-09 (~5 years ago), and the provider has reached multi‑million dollar Medicare billing within that timeframe. That rapid scaling to large claim volumes suggests a focused, transactional business model built around mass distribution of a single test product rather than gradual diversification of clinical services.
Payer reimbursement profile and operational implications: Average Medicare payment for K1034 is $12 avg paid/claim versus $3 avg paid/claim on Medicaid for the same code, indicating materially different reimbursement levels between payers. Coupled with 1.8M Medicare claims versus 6.1K Medicaid claims for K1034, the provider’s Medicare revenue is driven by both higher volume and higher per-claim payment, reinforcing Medicare dependency.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 1,818,470 | $10 | $21.8M |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
1 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| K1034 | 5 | 1,150 | 720 | $10 | $414.9K |
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 6,080 | $1 | $18.2K |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 4 | 60 | 660 | $1 | $3.2K |
Other providers in the same ZIP code as S K Diagnostics Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Rainbow Lab Inc | IL | Clinical Medical Laboratory | $15.1M | $9.7M |
| Az Labs Limited | IL | Clinical Medical Laboratory | $12.8M | $255.6K |
| Cl Labs Inc. | IL | Clinical Medical Laboratory | $166.5K | $11M |
| Safeena Enterprises Inc | IL | Clinical Medical Laboratory | $8.6M | $0 |
| Chicago Department Of Public Health | IL | Mental Health Clinic/Center (Including Community Mental Health Center) | $0 | $6.2M |
| Aza Labs Inc | IL | Clinical Medical Laboratory | $1M | $5M |
| County Diagnostic Incorporation | IL | Clinical Medical Laboratory | $5.3M | $92.8K |
| Abdulmassih Abdulmassih | IL | Family Medicine Physician | $374.7K | $3.3M |
| Kyriaki Ades | IL | Dentist | $0 | $3.6M |
| Aim One Incorporated | IL | Durable Medical Equipment & Medical Supplies | $0 | $3.4M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.